Sep 13, 2018

Philips new comprehensive obstetrical care solution increases comfort and mobility during labor

Philips Avalon beltless solution receives CE Mark coinciding with the 50th anniversary of Philips fetal monitoring solutions
Holistic obstetrical care solution provides seamless and continuous maternal and fetal monitoring for clinicians to intervene quickly

Amsterdam, The Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the Philips Avalon beltless solution, the latest addition to Philips comprehensive obstetrical care (OB) solution, has received CE mark approval. This system allows for continuous fetal and maternal monitoring that automatically streams patient data to the EMR through Philips obstetrical information management system, IntelliSpace Perinatal. The solution provides clinicians with the ability to monitor patients’ vital signs from their mobile devices through Avalon monitors, allowing clinicians to spend more time with the expectant mother. Celebrating 50 years as a trusted partner in obstetric care, Philips’ latest solution provides a holistic approach to caring for expectant mothers.

When it comes to fetal monitoring, mothers with high Body Mass Index (BMI) can be difficult to monitor using conventional ultrasound technology. However, according to a recent study, accuracy and reliability of fetal heart rate monitoring using abdominal fetal electrocardiogram were unaffected by maternal obesity [1]. Designed with electrode technology, the OB solution offers all expectant mothers, including women with high BMI, more mobility with the Avalon beltless solution, which enables clinicians to continuously monitor both fetal and maternal heart rates and uterine activity.

With comfort as a key priority, the solution allows expectant mothers to move freely during labor, connecting to the hospital wireless network while transmitting patient data back to the Avalon fetal monitors and then the EMR through the IntelliSpace Perinatal. This continuous patient data enables care teams to communicate effectively, perform informed clinical decisions wherever the patient is in the hospital and allow for quick intervention at the first sign of abnormality.

“Providing the best quality care for expectant mothers continues to be a priority for clinicians,” said Felix Baader, Business Leader, Monitoring and Analytics at Philips. “This is not only a great option for difficult-to-monitor patients with a higher BMI with synchronized information flow to the EMR, but it also offers comfort, freedom to move around and flexibility for expectant mothers during labor, improving their overall experience.”

This is not only a great option for difficult-to-monitor patients with a higher BMI with synchronized information flow to the EMR, but it also offers comfort, freedom to move around and flexibility for expectant mothers during labor, improving their overall experience.

Felix Baader

Business Leader, Monitoring and Analytics at Philips

The OB solution consists of the Avalon Fetal monitoring portfolio and its proprietary Smart Pulse technology, as well as an obstetrical information management system that focuses on the continuous obstetrical data flow to the EMR and includes:

The Avalon CL: a cableless fetal monitor base station that helps reduce the amount of cables, expands intrapartum and antepartum measurement parameters, and allows continuous monitoring when in the shower or while having a bath;
Avalon beltless solution: a single, easy-to-use patch and reusable pod that are placed on the expectant mother’s belly to capture critical parameters by measuring fetal and maternal heart rate and uterine activity through ECG and EMG signals;
Avalon CL wide range solution: an extension leveraging the hospital’s wireless LAN installation to allow mothers move further; and
IntelliSpace Perinatal: an obstetrical information management system designed to provide complete coverage from first antepartum visit through labor, delivery, postpartum, discharge and follow-up visits.

The Avalon beltless solution has received the CE Mark in Europe. Not available for sale in the U.S. For more information on the Philips OB solution, visit https://www.philips.com.au/healthcare/articles/fetal-monitoring-50th-anniversary.

[1] Cohen WR, Hayes- Gill B. Influence of maternal body mass index on accuracy and reliability of external fetal monitoring techniques. Acta Obstet Gynecol Scand 2014; 93:590–595.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Topics

Contacts

Kathy O'Reilly

Philips Global Press Office

Tel.: +1 978-221-8919

Ingrid Mitchell

Monitoring Analytics and Therapeutic Care

Tel.: +1 978-482-5949

Media assets

Philips OB solution allows clinicians to monitor patients’ vital signs from their mobile devices and enables expectant mothers to move freely during labor.